Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheon, Jae Hee | - |
dc.contributor.author | Kim, Nayoung | - |
dc.contributor.author | Lee, Dong Ho | - |
dc.contributor.author | Kim, Jung Mogg | - |
dc.contributor.author | Kim, Joo Sung | - |
dc.contributor.author | Jung, Hyun Chae | - |
dc.contributor.author | Song, In Sung | - |
dc.date.accessioned | 2022-12-21T11:23:06Z | - |
dc.date.available | 2022-12-21T11:23:06Z | - |
dc.date.created | 2022-09-16 | - |
dc.date.issued | 2006-05 | - |
dc.identifier.issn | 0954-691X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/181506 | - |
dc.description.abstract | Objectives To determine the long-term outcomes in terms of Helicobacter pylori and ulcer recurrence after second-line eradication with bismuth-containing quadruple regimens in Korea. Methods Sixty-seven patients with peptic ulcer disease after successful eradication using second-line quadruple therapies were prospectively followed up 1 month after treatment and then every 6 months or when dyspeptic symptoms reappeared to ascertain H. pylori and ulcer status. Results Three patients were lost during follow-up. The median duration of follow-up of the remaining 64 patients was 26.8 months. H. pylori recurrence occurred in 11 of these 64 patients (17.2%), giving a calculated reinfection rate of 6.0% per patient-year. Only one of the 11 patients was reinfected by 12 months after treatment completion. Four of 11 patients (36.4%) who became reinfected experienced peptic ulcer recurrence, but none of 53 patients who were not reinfected experienced recurrence. No evidence was obtained to indicate that the reinfection rate depended on the age, sex, ulcer location, or eradication regimens. The relapse of dyspeptic symptoms was the only factor predictive of H. pylori recurrence. Conclusion This study suggests that the recurrence rate of H. pylori at 1 year after second-line, bismuth-containing quadruple therapy is low, but the annual reinfection rate is as high as 6%. Surveillance for H. pylori reinfection facilitating peptic ulcer recurrence may be warranted even after a second eradication, especially when dyspeptic symptoms reappear in Korea. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.title | Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jung Mogg | - |
dc.identifier.doi | 10.1097/00042737-200605000-00010 | - |
dc.identifier.scopusid | 2-s2.0-33744786268 | - |
dc.identifier.wosid | 000243484600010 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, v.18, no.5, pp.515 - 519 | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | - |
dc.citation.title | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | - |
dc.citation.volume | 18 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 515 | - |
dc.citation.endPage | 519 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | DUODENAL-ULCER RECURRENCE | - |
dc.subject.keywordPlus | LENGTH-POLYMORPHISM ANALYSIS | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | REINFECTION RATE | - |
dc.subject.keywordPlus | TRIPLE THERAPY | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | STRAINS | - |
dc.subject.keywordPlus | RECRUDESCENCE | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordAuthor | Helicobacter pylori | - |
dc.subject.keywordAuthor | reinfection | - |
dc.subject.keywordAuthor | recrudescence | - |
dc.subject.keywordAuthor | quadruple | - |
dc.subject.keywordAuthor | bismuth | - |
dc.subject.keywordAuthor | second-line | - |
dc.identifier.url | https://journals.lww.com/eurojgh/Fulltext/2006/05000/Long_term_outcomes_after_Helicobacter_pylori.10.aspx | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.